Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate

J Antimicrob Chemother. 2006 Jun;57(6):1262-3. doi: 10.1093/jac/dkl102. Epub 2006 Mar 24.

Authors

Philippe R S Lagacé-Wiens, Kim A Nichol, Lindsay E Nicolle, Mel DeCorby, Melissa McCracken, Michael R Mulvey, George G Zhanel

PMID: 16565157
DOI: 10.1093/jac/dkl102

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Amoxicillin-Potassium Clavulanate Combination / pharmacology
Amoxicillin-Potassium Clavulanate Combination / therapeutic use*
Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Drug Resistance, Multiple, Bacterial*
Escherichia coli / drug effects*
Escherichia coli / isolation & purification
Escherichia coli Infections / drug therapy*
Escherichia coli Infections / microbiology
Humans
Male
Microbial Sensitivity Tests
Urinary Tract Infections / drug therapy*
Urinary Tract Infections / microbiology
beta-Lactamases / biosynthesis*

Substances

Anti-Bacterial Agents
Amoxicillin-Potassium Clavulanate Combination
beta-Lactamases